APA (7th ed.) Citation

PPJ, P., CA, P., TR, S., P, K., AH, D., E, G., . . . Jr, H. C. (2025). Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial. American journal of respiratory and critical care medicine, 211(7), 1277. https://doi.org/10.1164/rccm.202407-1354OC

Chicago Style (17th ed.) Citation

PPJ, Phillips, et al. "Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial." American Journal of Respiratory and Critical Care Medicine 211, no. 7 (2025): 1277. https://doi.org/10.1164/rccm.202407-1354OC.

MLA (9th ed.) Citation

PPJ, Phillips, et al. "Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial." American Journal of Respiratory and Critical Care Medicine, vol. 211, no. 7, 2025, p. 1277, https://doi.org/10.1164/rccm.202407-1354OC.